TIRZEPATIDE 5 No Label

Pack : Tirzepatide 5 mg x 1 vial

What is Tirzepatide (GIP and GLP-1 Receptor Agonist)?

Tirzepatide is a novel peptide drug that is a dual agonist of the GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptors. Both these receptors play a very important role in controlling blood glucose levels, and the dual action of Tirzepatide enhances the glucose regulatory ability of the body, especially in Type 2 diabetic patients. Tirzepatide is also very helpful in weight loss as it acts against appetite and metabolism.

Tirzepatide Benefits

Tirzepatide possesses numerous therapeutic benefits, some of which are listed below:

Regulation of Blood Sugar: It stimulates insulin secretion and inhibits glucagon secretion, leading to improved regulation of blood sugar, especially in diabetics.

Weight Loss: It has exhibited intensive activity in losing weight by controlling appetite and metabolism and thus proving to be helpful for both diabetics and non-diabetics.

Enhanced Cardiovascular Status: Tirzepatide can reduce cardiovascular risks by reducing cholesterol and blood pressure.

Anti-inflammatory Activity: It is also seen to inhibit inflammation, and this can be beneficial in patients with chronic inflammatory diseases such as diabetes.

ALSO KNOWN AS:
GIP and GLP-1 Receptor Agonist
Tirzepatide

Tirzepatide (GIP and GLP-1 Receptor Agonist) DOSAGE:
Tirzepatide (GIP and GLP-1 Receptor Agonist) 10mg/vial

Tirzepatide PEPTIDE INJECTIONS PACKAGE CONTENT:
1 Box of 1 Vial

HOW TO USE Tirzepatide PEPTIDE:
Tirzepatide is administered subcutaneously, generally once a week. Dosage should be titrated by blood glucose control and side effects with once-weekly clinical follow-up to optimize treatment.